On Chemball
My Chemball
+86-571-8627 3270
Shanghai Bocimed Pharmaceutical Co.,Ltd.
Shanghai Bocimed Pharmaceutical Co.,Ltd.
12 YRS
Shanghai, China
Main Products:
Relugolix / Carfilzomib / Ixazomib Citrate / Apalutamide / Avatrombopag / Fulvestrant / Lenvatinib Mesylate / Ruxolitinib Phosphate / Roxadustat / Brivaracetam
Shanghai, China
Send Email
Sending...
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
ABOUT US
Shanghai Bocimed Pharmaceutical Co., Ltd. (Bocimed) was established in Shanghai Zhangjiang Pharma Valley in 2012. Having two internal R&D centers settled in Shanghai and Nanjing, and a subsidiary clinical company in Chengdu, Bocimed now established an efficient R&D team with about 200 staffs and possesses specialized R&D equipments worth more 40 million RMB. Our comprehensive R&D platform mainly focuses upon small molecule innovative drugs, modified innovative drugs, highly difficult pharmaceutical preparations, DMF&MAH and clinical research, committing to provide global pharmaceutical companies with extremely competitive drug and create international and frontier pharmaceutical R&D and innovative platform.
Bocimed has more than 100 product development technologies, focusing on various therapeutic areas including oncology, cardiovascular science, immunology, neurological and mental health. With well-established internal intellectual property system,we have 16 authorized and 47 pending approval patents up to now.
Basic Information
Tax ID
91310000054592646Q
Country/Region
Shanghai, China
Year Established
2012
Registered Capital
CNY 39.8 Million
Business Type
CRO
Total Employees
100-500 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
Top 20 of China's top 100 enterprises of pharmaceutical industry (CRO / CDMO)
PLANT LOCATION
COMPANY ALBUM
